Experience

• 

  Notch Therapeutics

  • Canada
  • Biotechnology Research
  • 1 - 100 Employee

  • Associate Director, PSC Biology

    • Feb 2023 - Sep 2023

    • Led development and optimization of induced pluripotent stem cell (iPSC) differentiation platform for allogeneic immune cell therapy programs. • Acted as PSC subject matter expert on product development project teams, providing strategic input and technical advice.• Generated iPS-derived CD34+ hematopoietic progenitor cells and functional iPS-derived CD8+ αβ T-cells at research and pre-clinical scales. • Liaison with Process Development teams for tech transfer and scale-up of optimized cell differentiation protocols. • Established assays for in-depth characterization and quality assessment of differentiated cell products (e.g. flow cytometry, single cell RNA sequencing, live cell respirometry, functional assays). • Managed external collaborations, evaluated new technologies for potential in-licensing, fostered relationships with Scientific Advisory Board members. • Recruited, built and mentored a team of Scientists and Research Associates.

  • Senior Scientist, PSC Biology

    • Jun 2020 - Mar 2023

• 

  STEMCELL Technologies

  • Canada
  • Biotechnology Research
  • 700 & Above Employee

  • Senior Scientist

    • Oct 2016 - May 2020

    • Responsible for the Pluripotent Stem Cell (PSC) product portfolio including all aspects of new product development and product lifecycle management. • Proposed, developed, commercialized and launched novel products for hPSC maintenance and differentiation; launched multiple major top-selling products. • Identified and partnered with external collaborators for technology assessments, potential in-licensing, and product testing. Participated in international iPS cell therapy organizations. • Supported Quality and Regulatory requirements for cGMP ancillary reagents for cell therapy.• Led cross-functional matrixed project teams on high priority and high visibility projects.• Collaborated with groups across R&D on diverse projects including differentiation, scale-up, cell enrichment, and culture automation.• Subject matter expert in hPSC culture, banking, quality testing, cell-based assay development, and hematopoietic differentiation. Presented externally at conferences and training courses.

  • Scientist

    • May 2012 - Oct 2016

• 

  BC Cancer Agency

  • Canada
  • Medical Practices
  • 1 - 100 Employee

  • Postdoctoral Researcher

    • Apr 2011 - May 2012

  • Doctoral Student

    • Sep 2003 - Apr 2011

• 

  University of Alberta

  • Research Technician

    • 2001 - 2003